- Home
- NPV vs KOD Comparison
NPV vs KOD Comparison
Compare NPV & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- KOD
- Stock Information
- Founded
- NPV 1993
- KOD 2009
- Country
- NPV United States
- KOD United States
- Employees
- NPV N/A
- KOD N/A
- Industry
- NPV Investment Managers
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NPV Finance
- KOD Health Care
- Exchange
- NPV Nasdaq
- KOD Nasdaq
- Market Cap
- NPV 199.1M
- KOD 198.4M
- IPO Year
- NPV N/A
- KOD 2018
- Fundamental
- Price
- NPV $11.07
- KOD $8.62
- Analyst Decision
- NPV
- KOD Hold
- Analyst Count
- NPV 0
- KOD 3
- Target Price
- NPV N/A
- KOD $9.00
- AVG Volume (30 Days)
- NPV 38.9K
- KOD 607.6K
- Earning Date
- NPV 01-01-0001
- KOD 08-22-2025
- Dividend Yield
- NPV 3.90%
- KOD N/A
- EPS Growth
- NPV N/A
- KOD N/A
- EPS
- NPV N/A
- KOD N/A
- Revenue
- NPV N/A
- KOD N/A
- Revenue This Year
- NPV N/A
- KOD N/A
- Revenue Next Year
- NPV N/A
- KOD N/A
- P/E Ratio
- NPV N/A
- KOD N/A
- Revenue Growth
- NPV N/A
- KOD N/A
- 52 Week Low
- NPV $8.92
- KOD $1.92
- 52 Week High
- NPV $11.55
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- NPV 52.64
- KOD 68.37
- Support Level
- NPV $10.95
- KOD $7.69
- Resistance Level
- NPV $11.06
- KOD $8.45
- Average True Range (ATR)
- NPV 0.07
- KOD 0.78
- MACD
- NPV 0.02
- KOD 0.02
- Stochastic Oscillator
- NPV 84.78
- KOD 86.38
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.